Not updated yet!
Kinesis Pharma is the preferred provider for many innovative pharmaceutical companies that outsource their pharmacokinetic analysis, including some of the top 10 biggest pharmaceutical companies. A team of well trained PK/PD data analysts and report writers, supervised by experienced consultants with a solid background in clinical pharmacokinetics, is committed to delivering optimal quality within agreed timeframes for each PK/PD analysis. Noncompartmental PK analyses (NCA) have been performed for all type of Phase 1 studies including first-in-man, ADME studies, drug-drug interaction studies, bioequivalence and bioavailability studies, studies in special populations and other PK studies during phase 2/3. Specific software like Phoenix WinNonlin as well as SAS routines are among the programs used for NCA and reporting of the data in tables and graphs, including exploration of PK/PD relationships. Each pharmacokinetic analysis is performed according to GCP based standard operation procedures using validated software.